查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650894

全球癌症診斷藥物市場

Cancer Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球癌症診斷市場規模將達到 3,361 億美元

2024 年全球癌症診斷市場規模估計為 2,398 億美元，預計 2030 年將達到 3,361 億美元，2024 年至 2030 年的複合年成長率為 5.8%。診斷影像是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 6.8%，達到 953 億美元。在分析期內，臨床測試部分預計將以 4.1% 的複合年成長率成長。

美國市場規模估計為 625 億美元，中國市場預計年均成長率為 8.8%

預計2024年美國癌症診斷市場規模將達625億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 779 億美元，2024-2030 年分析期間的複合年成長率為 8.8%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.9% 和 5.3%。在歐洲，德國的複合年成長率預計為 3.4%。

全球癌症診斷市場 - 主要趨勢和促進因素摘要

為什麼癌症診斷處於醫學創新的前沿？

癌症診斷是醫療保健的關鍵領域，為癌症的早期發現、診斷和監測提供必不可少的工具，顯著改善患者的治療效果。準確、早期診斷癌症的能力對於成功治療和存活率有著巨大的影響。多年來，癌症診斷已從基本的影像技術發展到高度複雜的分子和基因測試，能夠識別特定的癌症類型、其進展以及可能影響治療決策的基因突變。各種診斷技術（包括切片檢查、血液檢查、成像（例如 MRI 和電腦斷層掃描）和基因組分析）的整合為臨床醫生提供了患者癌症的全面視圖。此外，液態切片和次世代定序（NGS）的進步徹底改變了早期癌症的檢測和監測方式。隨著該領域的進步，癌症診斷變得更加準確和個人化，在製定治療策略和提高患者存活率方面發揮關鍵作用。

科技創新如何推動癌症診斷？

科技創新的快速發展正在徹底改變癌症診斷領域，帶來能夠更準確、更早檢測的新工具和技術。最重要的發展之一是基因組和分子診斷的興起，它為了解驅動癌症生長的基因突變提供了基礎。次世代定序(NGS) 可以全面分析患者的基因特徵，幫助臨床醫生根據每個患者癌症的獨特特徵制定治療方案，使個人化醫療成為現實。液態切片是另一個尖端進步，可以透過簡單的血液檢查檢測出癌症。該技術不僅有助於早期發現，還能監測癌症的進展和治療的效果。人工智慧（AI）和機器學習也透過增強診斷成像、提高癌症篩檢的準確性以及比以往更快地解釋複雜資料集證明了其價值。這些創新簡化了診斷過程，實現了更早的檢測，並透過更精確和個人化的治療方法改善了患者的治療效果。

癌症診斷藥物面臨哪些新趨勢與挑戰？

目前，有幾個關鍵趨勢正在影響癌症診斷市場，每種趨勢都會影響癌症的檢測和管理方式。一個主要趨勢是對非侵入性診斷的需求不斷成長，例如液態切片和先進的成像技術，可以最大限度地減少患者的不適並減少獲得結果所需的時間。這種向微創方法的轉變正獲得患者和醫療保健提供者的支持，因為他們尋求更安全、更方便的選擇。另一個趨勢是人們越來越意識到癌症篩檢可以挽救生命，從而更加重視早期發現。乳癌、結腸癌、肺癌和其他癌症篩檢計畫的擴大，推動了對早期可發現癌症的診斷工具的需求。然而，該行業也面臨一些挑戰。先進診斷技術的複雜性和成本可能成為廣泛採用的障礙，尤其是在中低收入地區。此外，基因組檢測和影像診斷產生的大量資料需要複雜的資料管理和分析系統，這對醫療保健提供者在整合和解釋方面提出了挑戰。儘管存在這些挑戰，個人化醫療和早期檢測的趨勢繼續推動癌症診斷的創新。

癌症診斷藥物市場規模擴大的原因是什麼？

癌症診斷市場的成長受到多種因素的推動，包括技術進步、癌症發病率的上升以及對早期發現和個人化治療的日益重視。其中一個主要成長要素是分子診斷需求的激增，尤其是次世代定序（NGS）和液態切片技術，它們為檢測癌症提供了更準確、更少侵入性的選擇。此外，個人化醫療的興起，即根據個人基因特徵制定治療方案，刺激了對能夠識別特定生物標記和突變的診斷工具的需求。此外，由於人口老化和生活方式相關的風險因素等因素導致全球癌症發病率上升，也推動了對能夠更早發現癌症並改善患者預後的診斷解決方案的需求。此外，提倡定期癌症篩檢的政府措施和醫療政策也推動了對診斷測試的需求，尤其是在新興市場。此外，人工智慧和機器學習與診斷影像和資料分析的結合正在提高癌症檢測的準確性和速度，這也是推動市場成長的主要因素。這些因素，加上診斷能力向新興市場的持續擴張，預計未來幾年癌症診斷產業將保持快速成長。

部分

類型（影像、實驗室測試、基因測試、內視鏡檢查、切片檢查、其他類型）；應用（乳房、肺癌、血液、大腸直腸癌、皮膚、前列腺、卵巢、其他應用）

受訪公司範例（47家值得關注的公司）

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP10863

Global Cancer Diagnostics Market to Reach US$336.1 Billion by 2030

The global market for Cancer Diagnostics estimated at US$239.8 Billion in the year 2024, is expected to reach US$336.1 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$62.5 Billion While China is Forecast to Grow at 8.8% CAGR

The Cancer Diagnostics market in the U.S. is estimated at US$62.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$77.9 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Cancer Diagnostics Market - Key Trends and Drivers Summarized

Why Is Cancer Diagnostics at the Forefront of Medical Innovation?

Cancer diagnostics is a critical field within healthcare, providing essential tools for the early detection, diagnosis, and monitoring of cancer, significantly improving patient outcomes. The ability to diagnose cancer accurately and at an early stage can make a tremendous difference in treatment success rates and survival. Over the years, cancer diagnostics has evolved from basic imaging techniques to highly sophisticated molecular and genetic testing, enabling the identification of specific cancer types, their progression, and genetic mutations that may influence treatment decisions. The integration of various diagnostic technologies, such as biopsy, blood tests, imaging modalities (like MRI and CT scans), and genomic profiling, provides clinicians with a comprehensive view of a patient’s cancer. Moreover, advancements in liquid biopsy and next-generation sequencing (NGS) have transformed how early-stage cancer is detected and monitored. As the field advances, cancer diagnostics is becoming more precise and personalized, playing a crucial role in shaping treatment strategies and improving patient survival rates.

How Are Technological Innovations Driving Cancer Diagnostics?

The rapid pace of technological innovation is profoundly reshaping the cancer diagnostics landscape, bringing forth new tools and methodologies that allow for more accurate and earlier detection. One of the most significant developments has been the rise of genomic and molecular diagnostics, which provide insights into the genetic mutations driving cancer growth. Next-generation sequencing (NGS) enables the comprehensive analysis of a patient’s genetic profile, helping clinicians tailor treatments to the individual’s unique cancer characteristics, making personalized medicine a reality. Liquid biopsy, another cutting-edge advancement, allows for the detection of cancer through a simple blood test, offering a less invasive and faster alternative to traditional tissue biopsies. This technology is not only useful for early detection but also for monitoring cancer progression and treatment efficacy. Artificial intelligence (AI) and machine learning are also making their mark by enhancing imaging technologies, improving the accuracy of cancer screening, and allowing for the interpretation of complex datasets at an unprecedented speed. These innovations are streamlining diagnostic processes, enabling earlier detection, and facilitating better patient outcomes through more precise, individualized treatment approaches.

What Are the Emerging Trends and Challenges in Cancer Diagnostics?

Several key trends are currently shaping the cancer diagnostics market, each influencing how cancer is detected and managed. A major trend is the increasing demand for non-invasive diagnostics, such as liquid biopsy and advanced imaging techniques, which minimize patient discomfort and reduce the time needed to obtain results. This shift towards minimally invasive methods is gaining traction as patients and healthcare providers alike look for safer and more convenient options. Another trend is the growing emphasis on early detection, driven by rising awareness of cancer screening's life-saving potential. Screening programs for cancers such as breast, colorectal, and lung have expanded, leading to increased demand for diagnostic tools that can catch cancer at its earliest stages. However, the field faces several challenges as well. The complexity and cost of advanced diagnostic technologies can pose barriers to widespread adoption, particularly in low- and middle-income regions. Moreover, the sheer volume of data generated by genomic testing and imaging requires sophisticated data management and analysis systems, posing a challenge for healthcare providers in terms of integration and interpretation. Despite these challenges, the trend towards personalized medicine and early detection continues to propel innovation in cancer diagnostics.

What Factors Are Fueling the Expansion of the Cancer Diagnostics Market?

The growth in the cancer diagnostics market is driven by several factors, primarily advances in technology, rising cancer prevalence, and the increasing emphasis on early detection and personalized treatment. One of the key growth drivers is the surge in demand for molecular diagnostics, particularly next-generation sequencing (NGS) and liquid biopsy technologies, which provide more accurate and less invasive options for detecting cancer. The growing adoption of personalized medicine, where treatment plans are tailored to the individual’s genetic profile, has also spurred demand for diagnostic tools that can identify specific biomarkers and mutations. Additionally, the rising global incidence of cancer, driven by factors such as aging populations and lifestyle-related risk factors, is increasing the need for diagnostic solutions that can detect cancer early and improve patient outcomes. Government initiatives and healthcare policies promoting regular cancer screenings have also fueled the demand for diagnostic tests, particularly in developed markets. Another significant factor driving market growth is the integration of artificial intelligence and machine learning into diagnostic imaging and data analysis, which enhances the accuracy and speed of cancer detection. These factors, combined with the continued expansion of diagnostic capabilities into emerging markets, are expected to sustain the rapid growth of the cancer diagnostics industry in the years to come.

SCOPE OF STUDY:

The report analyzes the Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy, Other Types); Application (Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Globally Spurs Growth in Demand for Cancer Diagnostics
    • Technological Advancements in Genomics Throw the Spotlight on Precision Cancer Diagnostics
    • Growth in Personalized Medicine Expands Addressable Market Opportunity for Advanced Diagnostic Tools
    • Increasing Focus on Early Detection Propels Adoption of Non-Invasive Cancer Diagnostic Techniques
    • Growing Use of Liquid Biopsy Accelerates Demand for Minimal Invasive Cancer Diagnostic Methods
    • Expanding Applications of Biomarker Testing Sustain Growth in Cancer Diagnostics
    • Innovations in Imaging and Screening Generate New Opportunities for Early Cancer Detection
    • Shift toward Point-of-Care Diagnostics Strengthens Demand for Portable Cancer Diagnostic Tools
    • Growth in Molecular Diagnostics Expands Market Potential for Targeted Cancer Screening
    • Growing Use of Next-Generation Sequencing Accelerates Precision Cancer Diagnostics Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Skin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ovarian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 43: World Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION